Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan Long-term Safety in Hypertensive Children 6-17 Years
NCT01365481Phase 3Completed
- Sponsor
- Novartis
- Start
- Aug 2011
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of valsartan in hypertension (HTN), chronic kidney disease (CKD), sponsored by Novartis. Started Aug 2011; status: completed.
02
Drugs
valsartan
03
Conditions
hypertension (HTN)chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT01365481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01365481.